NCT01869504

Brief Summary

Drainage of air and fluid from the chest cavity using plastic tubes (chest drains) is an essential tool in Chest Medicine. A common complication of drain insertion is accidental removal of the drain, usually as a result of inadequate securing techniques, with rates of up to 1 in 5 reported. This often results in the need for further procedures (including drain re-siting), with associated additional risk to the patient and an increase in health care costs. One suggested method to reduce premature drain removal is to use chest drains with ballooned tips, much like a bladder catheter. These would provide a physical obstruction inside the chest cavity at the insertion site, whilst being easy to use as stitching or extensive taping may not be required. The investigators propose a trial of a dedicated ballooned chest drain to investigate whether a reduction in drain re-siting rates can be achieved. Pain scores will also be assessed during this trial to ensure that irritation of the lining of the lung or chest wall by the balloon is not excessive.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 5, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

May 22, 2017

Status Verified

May 1, 2017

Enrollment Period

4 months

First QC Date

February 26, 2013

Last Update Submit

May 19, 2017

Conditions

Keywords

Ballooned intercostal drainPleural effusion

Outcome Measures

Primary Outcomes (1)

  • The percentage of intercostal drains requiring re-siting

    It is likely that most if not all of the drains will have been removed by this time owing to resolution of the effusion, but the time period of 7 days has been selected to allow maximum data capture.

    7 days

Secondary Outcomes (2)

  • Patient reported pain scores, using a visual analogue scale

    At 24 hours, 72 hours, and at drain removal, an expected average of 5 days

  • The frequency of balloon rupture

    7 days

Study Arms (1)

Balloon-tipped intercostal drain

EXPERIMENTAL

Subjects who have given written informed consent and who fulfill the inclusion and exclusion criteria will proceed to have the study drain inserted at the earliest opportunity as per standard hospital protocols using local anaesthetic, and conscious sedation where appropriate. All other aspects of their treatment will be identical to usual clinical care, including chest drain checks and fluid drainage strategies.

Device: Balloon-tipped intercostal drain

Interventions

Ballooned intercostal drain for pleural effusion, inserted using local anaesthetic and ultrasound guidance.

Also known as: Manufactured by Rocket Medical.
Balloon-tipped intercostal drain

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>16 years
  • Able to give written informed consent
  • Requiring intercostal tube drainage of a pleural effusion for clinical reasons

You may not qualify if:

  • Requiring intercostal tube drainage for chest trauma
  • Requiring blunt dissection for drain insertion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's Mill Hospital

Sutton in Ashfield, Nottinghamshire, NG17 4JL, United Kingdom

Location

MeSH Terms

Conditions

Pleural Effusion

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract Diseases

Study Officials

  • Samuel V Kemp, MBBS

    Sherwood Forest Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2013

First Posted

June 5, 2013

Study Start

February 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

May 22, 2017

Record last verified: 2017-05

Locations